Morningstar Investment Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-83,831
| Closed | -$13.9M | – | 219 |
|
|
2022
Q1 | $13.9M | Buy |
83,831
+1,264
| +2% | +$209K | 0.15% | 106 |
|
|
2021
Q4 | $14M | Buy |
82,567
+1,973
| +2% | +$335K | 0.16% | 106 |
|
|
2021
Q3 | $14.3M | Buy |
80,594
+1,427
| +2% | +$253K | 0.17% | 102 |
|
|
2021
Q2 | $13.1M | Buy |
79,167
+2,617
| +3% | +$434K | 0.16% | 104 |
|
|
2021
Q1 | $10.3M | Buy |
+76,550
| New | +$10.3M | 0.13% | 115 |
|